Request a copy

Full Text

• Cook, D. L.; Hales, C. N. Intracellular ATP Directly Blocks K+ Channels in Pancreatic B Cells. Nature 1984, 311, 271-273.
• Standen, N. B.; Quayle, J. M.; Davies, N. W.; Brayden, J. E.; Huang, Y.; Nelson, M. T. Hyperpolarizing Vasodilators Activate ATP-Sensitive K+ Channels in Arterial Smooth Muscle. Science 1989, 245, 177-180.
• Ashcroft, F. M. Adenosine 5′-Triphosphate-Sensitive Potassium Channels. Annu. Rev. Neurosci. 1988, 11, 97-118.
• Petersen, O. H.; Dunne, M. J. Regulation of K+ Channels Plays a Crucial Role in the Control of Insulin Secretion. Pfluegers Arch. 1989, 414, S115-S120.
• Kolb, H. A. Potassium Channels in Excitable and Non-Excitable Cells. Rev. Physiol. Biochem. Pharmacol. 1990, 15, 51-79.
• Babenko, A. P.; Aguilar-Bryan, L.; Bryan, J. A View of SUR/Kir 6.X KATP Channels. Annu. Rev. Physiol. 1998, 60, 667-687.
• Robertson, D. W.; Steinberg, M. I. Potassium Channel Modulators: Scientific Applications and Therapeutic Promise. J. Med. Chem. 1990, 33, 1529-1541.
• Lebrun, P.; Arkhammar, P.; Antoine, M.-H.; Nguyen, Q.-A.; Hansen, J. B.; Pirotte, B. A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release. Diabetologia 2000, 43, 723-732.
• Björk, E.; Berne, C.; Kämpe, O.; Wibell, P.; Oskarsson, P.; Karlsson, F. A. Diazoxide Treatment at Onset Preserves Residual Insulin Secretion in Adults with Autoimmune Diabetes. Diabetes 1996, 45, 1427-1430.
• Alemzadeh, R.; Langley, G.; Upchurch, L.; Smith, P.; Slonim, A. E. Beneficial Effect of Diazoxide in Obese Hyperinsulinemic Adults. J. Clin. Endocrinol. Metab. 1998, 83, 1911-1915.
• Pirotte, B.; de Tullio, P.; Lebrun, P.; Antoine, M.-H.; Fontaine, J.; Masereel, B.; Schynts, M.; Dupont, L.; Herchuelz, A.; Delarge, J. 3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-Dioxides as Powerful Inhibitors of Insulin Release from Rat Pancreatic B-Cells: A New Class of Potassium Channel Openers? J. Med. Chem. 1993, 36, 3211-3213.
• de Tullio, P.; Pirotte, B.; Lebrun, P.; Fontaine, J.; Dupont, L.; Antoine, M.-H.; Ouedraogo, R.; Khelili, S.; Maggetto, C.; Masereel, B.; Diouf, O.; Podona, T.; Delarge, J. 3- and 4-Substituted 4H-Pyrido[4,3-e]-1,2,4-thiadiazine 1,1-Dioxides as Potassium Channel Openers: Synthesis, Pharmacological Evaluation, and Structure-Activity Relationships. J. Med. Chem. 1996, 39, 937-948.
• Pirotte, B.; Antoine, M.-H.; de Tullio, P.; Hermann, M.; Herchuelz, A.; Delarge, J.; Lebrun, P. A Pyridothiadiazine (BPDZ 44) as a New and Potent Activator of ATP-Sensitive K+ Channels. Biochem. Pharmacol. 1994, 47, 1381-1386.
• Antoine, M.-H.; Pirotte, B.; Hermann, M.; de Tullio, P.; Delarge, J.; Herchuelz, A.; Lebrun, P. Cationic and Secretory Effects of BPDZ 44 and Diazoxide in Rat Pancreatic Islets. Experientia 1994, 50, 830-832.
• Khelili, S.; de Tullio, P.; Lebrun, P.; Fillet, M.; Antoine, M.-H.; Ouedraogo, R.; Dupont, L.; Fontaine, J.; Felekidis, A.; Leclerc, G.; Delarge, J.; Pirotte, B. Preparation and Pharmacological Evaluation of the R- and S-Enantiomers of 3-(2′-Butylamino)-4H- and 3-(3′-Methyl-2′-butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-Dioxide, Two Tissue Selective ATP-Sensitive Potassium Channel Openers. Bioorg. Med. Chem, 1999, 7, 1513-1520.
• Pirotte, B.; Ouedraogo, R.; de Tullio, P.; Khelili, S.; Somers, F.; Boverie, S.; Dupont, L.; Fontaine, J.; Damas, J.; Lebrun, P. 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-Dioxides Structurally Related to Diazoxide and Pinacidil as Potassium Channel Openers Acting on Vascular Smooth Muscle Cells: Design, Synthesis and Pharmacological Evaluation. J. Med. Chem. 2000, 43, 1456-1466.
• Dabrowski, M.; Ashcroft, F. M.; Ashfield, R.; Lebrun, P.; Pirotte, B.; Egebjerg, J.; Hansen, J. B.; Wahl, P. The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener. Diabetes 2002, 51, 1896-1906.
• Somers, F.; Ouedraogo, R.; Antoine, M.-H.; de Tullio, P.; Becker, B.; Fontaine, J.; Damas, J.; Dupont, L.; Rigo, B.; Delarge, J.; Lebrun, P.; Pirotte, B. Original 2-Alkylamino-6-halogenoquinazolin-4(3H)-ones and KATP Channel Activity. J. Med. Chem. 2001, 44, 16, 2575-2585.
• Girard, Y.; Atkinson, J. G.; Rokach, J. A New Synthesis of 1,2,4-Benzothiadiazines and a Selective Preparation of o-Aminobenzenesulphonamides. J. Chem. Soc., Perkin Trans. 1 1979, 1043-1047.
• Wollweber, H.; Horstmann, H.; Stoepel, K.; Garthoff, B.; Puls, W.; Krause, H. P.; Thomas, G. 3-Amino-2H-benzothiadiazine-1,1-dioxide mit Antihypertensiver und Potentieller Diabetogener Wirkung (3-Amino-2H-benzothiadiazine 1,1-dioxide with antihypertensive and potential diabetogenic effect). Arzneim.-Forsch. 1981, 31, 279-288.
• Manley, P. W.; Quast, U. Structure-Activity Studies of Potassium Channel Opening in Pinacidil-Type Cyanoguanidines, Nitroethenediamines, Thioureas, and Ureas. J. Med. Chem. 1992, 35, 2327-2340.
• Quast, U.; Bray, K. M.; Andres, H.; Manley, P. W.; Baumlin, Y.; Dosogne, J. Binding of the K+ Channel Opener [3H]P1075 in Rat Isolated Aorta: Relationship to Functional Effects of Openers and Blockers. Mol. Pharmacol. 1993, 43, 474-481.
• Lebrun, P.; Antoine, M.-H.; Ouedraogo, R.; Dunne, M.; Kane, C.; Hermann, M.; Herchuelz, A.; Masereel, B.; Delarge, J.; de Tullio, P.; Pirotte, B. Activation of ATP-Dependent K+ Channels and Inhibition of Insulin Release: Effect of BPDZ 62. J. Pharmacol. Exp. Ther. 1996, 277, 156-162.
• de Tullio, P.; Pirotte, B.; Dupont, L.; Masereel, B.; Laeckmann, D.; Podona, T.; Diouf, O.; Lebrun, P.; Delarge, J. Synthesis and Structural Studies of a New Class of Heterocyclic Compounds: 1,2,4-Pyridothiadiazine 1,1-Dioxides, Pyridyl Analogues of 1,2,4-Benzothiadiazine 1,1-Dioxides. Tetrahedron 1995, 51, 3221-3234.
• March, J. Advanced Organic Chemistry, 3rd ed.; Wiley: New York, 1985.
• Dupont, L.; de Tullio, P.; Tinant, B.; Pirotte, B. (R/S)-3-(3-Methyl-2-butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-Dioxide Monohydrate. Acta Crystallogr. 2001, E57, o1050-o1051.
• Dupont, L.; Pirotte, B.; de Tullio, P. 7-Iodo-3-isopropylamino-4H-1,2,4-benzothiadiazine 1,1-Dioxide. Acta Crystallogr. 1999, C55, 1152-1154.
• Di Bella, M.; Monzani, A.; Albasini, A.; Conti, G. Ricerche Nel Campo della 1,2,4-Benzotiadiazina (Searches in the Field of 1,2,4-Benzothiadiazines). Farmaco 1966, 12, 829-838.
• Di Bella, M.; Rinaldi, M.; Coppi, G.; Fabio, U.; Manicardi, G. Azione Antimicrobica di Derivati dell' 1,2,4-Benzotiadiazin-1,1-diossido (Antimicrobial action of derivatives of 1,2,4-benzothiadiazine 1,1-dioxide). Farmaco 1974, 29, 915-922.
• Di Bella, M.; Rinaldi, M.; Fabio, U.; Manicardi, G. Azione Antimicrobica di Derivati dell'1,2,4-Benzotiadiazin-1,1-diossido (Antimicrobial action of derivatives of 1,2,4-benzothiadiazine 1,1-dioxide). Farmaco 1972, 27, 990-998.
• Parenti, C.; Constantino, L.; Di Bella, M.; Raffa, L.; Baggio, G. G.; Rossi, T. Heteroaryl-alkanoic Acids with Possible Antiinflammatory Activities IV. Boll. Chim. Farm. 1987, 126, 239-243.
• Raffa, L.; Di Bella, M.; Ferrari, P.; Rinaldi, M.; Ferrari, N. Azione Cardiovasculare di Derivati dell'1,2,4-Benzothiadiazin-1,1-diossido. Nota IV (Cardiovascular Action of Derivatives of 1,2,4-Benzothiadiazine 1,1-Dioxide. Part IV). Farmaco, Ed. Sci. 1974, 29, 411-423.
• Di Bella, M.; Rinaldi, M.; Fabio, U.; Manicardi, G. Azione Antimicrobica di Derivati dell'1,2,4-Benzotiadiazin-1,1-diossido (Antimicrobial Action of Derivatives of 1,2,4-Benzothiadiazine 1,1-Dioxide). Farmaco 1973, 28, 411-417.
• Leclercq-Meyer, V.; Marchand, J.; Woussen-Colle, M. C.; Giroix, M.-H.; Malaisse, W. J. Multiple Effects of Leucine on Glucagon, Insulin, and Somatostatin Secretion from the Perfused Rat Pancreas. Endocrinology 1985, 116, 1168-1174.
• Tucker, S. J.; Gribble, F. M.; Zhao, C.; Trapp, S.; Ashcroft, F. M. Truncation of Kir6.2 Produces ATP-sensitive K-channels in the Absence of the Sulphonylurea Receptor. Nature 1997, 387, 179-181.
• Gribble, F. M.; Ashfield, R.; Ämmälä, C.; Ashcroft, F. M. Properties of Cloned ATP-Sensitive K-Currents Expressed in Xenopus Oocytes. J. Physiol. 1997, 498, 87-98.